CLDX : Summary for Celldex Therapeutics, Inc. - Yahoo Finance

U.S. Markets close in 2 hrs 28 mins

Celldex Therapeutics, Inc. (CLDX)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.67-0.09 (-2.40%)
As of 1:31 PM EST. Market open.
People also watch:
ACADCLVSARRYSRPTSGEN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close3.76
Open3.70
Bid3.67 x 900
Ask3.68 x 1600
Day's Range3.62 - 3.78
52 Week Range2.85 - 16.65
Volume1,025,389
Avg. Volume2,442,980
Market Cap371.57M
Beta2.77
PE Ratio (TTM)-2.83
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube1 hour ago

    ETFs with exposure to Celldex Therapeutics, Inc. : December 8, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Celldex Therapeutics, Inc. Here are 5 ETFs with the largest exposure to CLDX-US. Comparing the performance and risk of Celldex Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Is Celldex Therapeutics (CLDX) Stock a Solid Choice Right Now?
    Zacksyesterday

    Is Celldex Therapeutics (CLDX) Stock a Solid Choice Right Now?

    Celldex Therapeutics (CLDX) is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.

  • Why Celldex Rallied 22% In November
    Motley Foolyesterday

    Why Celldex Rallied 22% In November

    The aspiring drug developer closed on an acquisition and updated investors on its clinical trial progress last month.